Intelligence » Diabetes » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    How an existing diabetes drug controls pancreatic cancer

    Thursday, March 15, 2018 -- A new study suggests that targeting the RET signaling pathway with metformin might offer a new way to stop the growth and spread of pancreatic cancer.

    Folic Acid Overconsumption May Contribute to Diabetes

    Thursday, March 15, 2018 -- A study recently published in Frontiers in Endocrinology by researchers from the Diabetes Research Institute at the University of Miami, discusses that folic acid overconsumption may be linked to the development of type 1 and type 2 diabetes. What It Is Folate (vitamin B9) is naturally found in foods such as leafy green vegetables, lentils, […]

    How Many Get Kidney Disease After 40 Years With Type 1 Diabetes?

    Tuesday, March 20, 2018 -- End-stage renal disease (ESRD) occurs when chronic kidney disease has progressed to its last stages. It’s one of the more feared diabetes complications. As the Mayo Clinic states, “With end-stage renal disease, you need dialysis or a kidney transplant to stay alive. But you may also choose to forgo dialysis or transplant and opt for […]

    New diabetes drug may help obese people shed body weight

    Monday, March 19, 2018 -- A compound that mimics a naturally occurring hormone that regulates appetite may help people who have obesity but not diabetes to lose weight, a new study suggests.

    Poor dental health may be related to increased diabetes risk

    Tuesday, March 20, 2018 -- Poor dental health may be linked with increased risk for diabetes, a new study suggests. The results will be presented in a poster Monday, March 19, at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill.

    Can Fenofibrate Help Ease Gout in Type 2 Diabetes?

    Thursday, March 15, 2018 -- People with type 2 diabetes often suffer from gout, which is a painful rheumatic disease occurring when too much uric acid accumulates and affects the joints. Researchers wondered whether fenofibrate could reduce uric acid and lower the number of gout episodes in users. Fenofibrate is a medication used to lower LDL cholesterol and triglycerides as […]

    Vitamin D protects against chronic inflammation and insulin resistance in obese patients

    Sunday, March 18, 2018 -- (Natural News) The link between obesity and increased insulin levels is a well-established indicator of diabetes. Fortunately, there’s still hope: A study that appeared in Nutrire found that vitamin D protects the body from chronic inflammation and insulin resistance in obese individuals. The study, led by researchers from the Federal University of Piauí in Brazil, reviewed studies... Read More

    Advanced insulin pump system can also manage type 1 diabetes in children, study shows

    Tuesday, March 20, 2018 -- The MiniMed 670G insulin pump system (Medtronic, Northridge, California) can improve glycemic outcomes in children with type 1 diabetes as young as 7 years of age, according to an industry-funded study.

    No more needles: Diabetics can now monitor blood sugar levels through tears or sweat with a new biosensor

    Sunday, March 18, 2018 -- (Natural News) The first step in fighting back against diabetes is checking to see if a patient does indeed have it in the first place. In most cases, this is done through tracking a person’s glucose levels through their blood, which means going with the conventional prick method. This entails performing a slightly invasive and... Read More

    High-energy breakfast reduces weight, improves diabetes control

    Monday, March 19, 2018 -- Daniela JakubowiczCHICAGO — A meal schedule consisting of a high-energy breakfast and lunch with a low-energy dinner yielded greater weight loss and decreases in BMI, HbA1c, overall glycemia and total daily insulin dose in patients with uncontrolled type 2 diabetes and obesity compared with a meal schedule focused on six small meals throughout the day.“It is believed that those people who eat more in the evening gain weight more [easily] than those who consume more calories in the morning,” Daniela Jakubowicz, MD, professor of medicine at Tel Aviv University, Israel, said

    Study finds diabetes patients could suffer undiagnosed kidney damage before diagnosis

    Friday, March 16, 2018 -- Researchers maintain some diabetes patients may have suffered from undiagnosed kidney damage before learning they had the disease.© Shutterstock Data from Veterans Affairs (VA) electronic health records published in PLoS One determined more than 30 percent of diabetic veterans had … Read More » The post Study finds diabetes patients could suffer undiagnosed kidney damage before diagnosis appeared first on Life Science Daily.

    Can Acarbose Reduce Both Cardiovascular Disease and Diabetes?

    Tuesday, March 20, 2018 -- Drugs known to reduce cardiovascular problems or diabetes are staples in the medical community. A recent study, named the ACE Trial, evaluated the effectiveness of acarbose to reduce the incidence of cardiovascular disease and diabetes. With over 230 million people with heart disease in China, effective medication for this population is essential.Due to population growth […] The post Can Acarbose Reduce Both Cardiovascular Disease and Diabetes? appeared first on Medical News Bulletin | Health News and Medical Research.

    Changes in the intestines may be responsible for reversal of diabetes after bariatric surgery

    Monday, March 19, 2018 -- A new study helps explain changes in the intestines that may be responsible for the reversal of diabetes in people who undergo a type of bariatric surgery known as Roux-en-Y gastric bypass surgery.

    Consumption of low-calorie sweeteners could promote metabolic syndrome, increase diabetes risk

    Monday, March 19, 2018 -- Consumption of low-calorie sweeteners could promote metabolic syndrome and predispose people to prediabetes and diabetes, particularly in individuals with obesity, a new study on human fat-derived stem cells and fat samples suggests.

    Hormone imbalance may be reason for higher diabetes rates among men with insufficient sleep

    Monday, March 19, 2018 -- Studies have found an association between insufficient sleep and the development of insulin resistance, one of the factors that cause type 2 diabetes, and now researchers have discovered a biological reason for this relationship, at least in men: an imbalance between their testosterone and cortisol hormones.

    Diabetes medication reduces chance of late miscarriage, premature birth among women with PCOS

    Tuesday, March 20, 2018 -- The oral diabetes medication metformin seems to reduce the chance of a late miscarriage and premature birth among women with polycystic ovary syndrome but does not affect their rate of developing gestational diabetes, a multicenter study finds.

    Real world data back Sanofi’s Toujeo for type I diabetes

    Tuesday, March 20, 2018 -- Sanofi has unveiled real-world data from the UK showing the efficacy of its long-acting basal insulin analogue Toujeo in treating patients in type I diabetes.

    Dementia Risk Triples with Diabetes and Depression: Study

    Tuesday, March 20, 2018 -- In the past, research has shown that the development of dementia later in life is connected to type 2 diabetes and depression, respectively. A new study, however, has shown for the first time that the risk of developing dementia is … The post Dementia Risk Triples with Diabetes and Depression: Study appeared first on Bel Marra Health - Breaking Health News and Health Information.

    CVD-REAL 2: SGLT2 inhibitors decrease risk for CV events, death in type 2 diabetes

    Friday, March 16, 2018 -- ORLANDO, Fla. — Patients with type 2 diabetes who were treated with sodium-glucose cotransporter 2 inhibitors had a decreased risk for HF hospitalization, death, stroke and MI compared with those who were treated with other glucose-lowering drugs, according to data from featured clinical research presented at the American College of Cardiology Scientific Session.“The directionality of associations was generally consistent across countries, and results were stable in multiple sensitivity analyses and across patient subgroups,” Mikhail Kosiborod, MD, professor of medicine at

    Artificial pancreas safe, effective in young children with type 1 diabetes

    Monday, March 19, 2018 -- Michael Alan WoodCHICAGO — Children aged 7 to 13 years with type 1 diabetes who used an artificial pancreas system for 3 months experienced a reduction in HbA1c and an improvement in time to glucose values in the target range, without any episodes of severe hypoglycemia or diabetic ketoacidosis, according to study data presented here.“Diabetes management, especially with children, is a challenge,” Michael Alan Wood, MD, associate professor of pediatrics and clinical director of the pediatric diabetes program at the University of Michigan Medical School in Ann Arbor, said